today announced that the Compensation Committee of Autonomix’s Board of Directors approved the grant of an inducement stock option on March 17, 2025 to purchase 7,500 shares of the Company’s ...

The CMO Inducement Grant has an exercise price per share that is equal to the closing price of Viridian’s common stock on the CMO Grant Date. The CMO Inducement Grant will vest over a four-year ...

Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104 ...

2025 an equity inducement award to Andrew Gengos, the Company’s new chief financial officer, under the terms of the 2022 Employment Inducement Award Plan, as amended. The equity award was ...

The approved inducement grant comes as Etsy targets a stickier app experience as part of a strategy to reverse an ongoing ...

European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the leading franchisor and operator of out-of-home waxing services in the United States, announced that on March 21, ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies ...

Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Cogent also announced today that the Compensation Committee of Cogent’s Board of Directors, made up entirely of independent directors ...

iRobot granted Mr. Lanouette an employment inducement award consisting of 120,000 time-based restricted stock units ("RSUs") with an effective grant date of March 21, 2025. The RSUs will vest over ...

Annexon Biosciences (Nasdaq: ANNX) is developing therapeutics that stop classical complement-driven neurodegeneration as first-in-kind treatments for millions of people living with serious ...

Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company focused on advancing innovative technologies to revolutionize ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib fo ...